Finasteride

The multi-billion dollar hair loss industry is flooded with ineffective shampoos, vitamins, and laser combs that promise miraculous results. However, modern dermatology acknowledges only two FDA-approved treatments for Androgenetic Alopecia (male pattern baldness): Minoxidil and Finasteride.

While Minoxidil acts as a growth stimulant (fertilizer for the hair), Finasteride acts as the biological shield. Male hair loss is fundamentally driven by an androgenic cascade. Testosterone circulating in your bloodstream encounters an enzyme called Type II 5-alpha reductase, heavily concentrated in the dermal papilla of hair follicles. This enzyme converts testosterone into Dihydrotestosterone (DHT).

In men with a genetic predisposition, scalp follicles are exquisitely sensitive to DHT. When DHT binds to the follicle, it triggers follicular miniaturization—a process where the growth phase (anagen) gets progressively shorter, and the resting phase (telogen) gets longer. Over several years, thick terminal hairs are reduced to invisible, peach-fuzz-like vellus hairs, until the follicle undergoes apoptosis (programmed cell death) and closes permanently.

Finasteride physically binds to the 5-alpha reductase enzyme, disabling it. By dropping systemic and scalp DHT levels by nearly 70%, it removes the biological trigger of miniaturization.

The protective nature of Finasteride extends beyond simply blocking a hormone. Clinical pathology shows that DHT-induced hair loss is actually a highly inflammatory process that leads to microscopic scarring beneath the scalp.

A fascinating in-vitro study published in the Biological & Pharmaceutical Bulletin (PMID: 16755026) demonstrated exactly how this works. Researchers found that androgens induce the expression of Transforming Growth Factor-beta 1 (TGF-beta1), which promotes heavy fibrosis (scarring) around the follicle. They discovered that pre-treatment with Finasteride actively suppressed this TGF-beta1 expression, suggesting that Finasteride doesn't just stop hormones—it stops the physical, structural scarring of the scalp.

Because hair grows slowly (roughly half an inch per month), evaluating the true efficacy of a hair loss intervention requires looking at multi-year, long-term clinical data.

Longitudinal Efficacy

Sustainable Follicular Defense

Unlike cosmetic treatments that offer temporary illusions of thickness, 1mg of daily finasteride alters the biological timeline of the scalp, providing continuous protection for years.

A massive systematic review published in the Archives of Dermatology (PMID: 20956649) evaluated decades of randomized controlled trials. The consensus was overwhelming: 1mg oral finasteride provided a highly significant, continuous increase in hair count and visible clinical improvement compared to placebo across thousands of adult men.

More recently, a definitive 5-year retrospective study published in the Journal of Dermatology (PMID: 30536893) tracked over 120 men taking 1mg of finasteride daily. The researchers found that an incredible 85.7% of patients showed objective clinical improvement after 5 years of treatment. Notably, hair loss at the vertex (the crown of the head) showed the most rapid and steady improvement, halting progression entirely in the vast majority of patients. The data concluded that finasteride offers sustainable, long-term efficacy without diminishing returns over half a decade of use.

Historically, Finasteride has been prescribed as a 1mg oral tablet. While highly effective, taking the medication orally suppresses DHT systemically (throughout the entire body), not just on the scalp. For patients concerned about systemic hormonal shifts, dermatological compounding has recently perfected Topical Finasteride.

Topical finasteride is applied directly to the scalp as a liquid serum or spray, bypassing the digestive tract and liver. This allows the medication to concentrate heavily in the hair follicles where the 5-alpha reductase enzyme lives, minimizing the amount of the drug that enters the general bloodstream.

A landmark Phase III, randomized, double-blind clinical trial published in the Journal of the European Academy of Dermatology and Venereology (PMID: 34634163) compared topical finasteride directly against the oral tablet over 24 weeks. The study yielded incredible results:

• Equivalent Hair Growth:

  The target area hair count (TAHC) increases were numerically similar between the topical and oral groups. Both effectively halted loss and stimulated new terminal hair growth.

• Drastically Lower Systemic Impact:

  Crucially, maximum plasma concentrations of the drug were over 100 times lower in the topical group. While oral finasteride reduced serum (blood) DHT by over 55%, the topical spray only reduced it by ~34%, leaving far more systemic DHT intact for general male vitality while still protecting the scalp.

At Scripten, our physician network offers access to both oral tablets and highly calibrated compounded topical solutions, allowing you to choose the protocol that best fits your biological goals.

Because Finasteride alters male androgens, its safety profile is frequently debated online. In clinical practice, the drug is remarkably well-tolerated. In massive FDA trials, approximately 1-2% of men reported sexual side effects (such as lowered libido or mild erectile dysfunction), which generally resolved entirely upon discontinuing the medication.

However, the internet has amplified reports of a condition known as Post-Finasteride Syndrome (PFS)—a proposed state where sexual and depressive side effects persist long after the drug is stopped. A comprehensive review in The Aging Male (PMID: 30651009) investigated the reality of PFS. The researchers acknowledged that while a very small subset of susceptible individuals do report persistent iatrogenic symptoms, it remains a rare occurrence.

The medical consensus suggests that the vast majority of men will not experience long-term adverse events. Furthermore, utilizing topical formulations or lowering the oral dosage frequency (e.g., taking the pill 3 times a week instead of daily, due to its long tissue half-life) can drastically mitigate any potential side effects while maintaining near-maximum hair protection.